ArriVent reports phase 1 data for cancer drug ARR-217
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Dominance-seeking workers see more sexual interest in coworkers’ behavior, and that may help explain harassment
A smile or friendly chat at work isn’t usually an invitation. But employees with a strong desire to dominate others were more likely to read sexual interest into such behavior, and those perceptions…
Rotary Reaffirms Its Commitment To Sustaining India's Polio-Free Status & Supporting Global Polio Eradication
Mumbai: In a powerful demonstration of unity and commitment towards a polio-free world, the Rotary Club of Bombay and the India National Polio Plus Advisory Council organised “A Thousand Voices”, an…
Shortage of oncology nurses threatens cancer care delivery in Nigeria
Nursing professionals have called for improved welfare, increased training opportunities and greater inclusion in health sector decision-making, warning that the shortage of oncology nurses is…
Ethnic minorities in England less likely to get breast cancer diagnosis from routine screening
Exclusive: People from marginalised groups more likely to be diagnosed via urgent referral or in emergency setting, research finds People from minority ethnic backgrounds in England are up to a third…
SGLT2 Inhibitors Tied to Uptick in Hemoglobin and Hematocrit
(MedPage Today) -- DENVER -- Treatment with SGLT2 inhibitors was linked with modest but statistically significant increases in hemoglobin and hematocrit levels across a broad spectrum of patient…
Health board still paying for research despite criticism over patient benefit
Betsi Cadwaladr health board was due to pay Bangor University £110,686 for two researchers.